The many faces of the anti-COVID immune response
Keyword(s):
The Many
◽
The novel 2019 strain of coronavirus is a source of profound morbidity and mortality worldwide. Compared with recent viral outbreaks, COVID-19 infection has a relatively high mortality rate, the reasons for which are not entirely clear. Furthermore, treatment options for COVID-19 infection are currently limited. In this Perspective, we explore the contributions of the innate and adaptive immune systems to both viral control as well as toxicity during COVID-19 infections and offer suggestions to both understand and therapeutically modulate anti-COVID immunity.
2021 ◽
Vol 288
(1961)
◽
2013 ◽
Vol 3
(5)
◽
pp. 207-213
2017 ◽
2018 ◽
Vol 34
(12)
◽
pp. 2007-2014
◽
2019 ◽
2021 ◽
Vol 71
(2)
◽
pp. 61-64